The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Molecular Communication and Nanonetwork for Targeted Drug Delivery: A Survey
Abstract
Molecular communication (MC) and molecular network (MN) are communication paradigms that use biochemical signaling to achieve information exchange among naturally and artificially synthesized nanosystems. Among the envisaged application areas of MC and MN is the field of nanomedicine, where the subject of targeted drug delivery (TDD) is at the forefront. Typically, when someone gets sick, therapeutic drugs are administered to the person for healing purposes. Since no therapeutic drug can be effective until it is delivered to the target site in the body, different modalities to improve the delivery of drugs to the targeted sites are being explored in contemporary research. The most promising of these modalities is TDD. TDD modality promises a smart localization of appropriate dose of therapeutic drugs to the targeted part of the body at reduced system toxicity. Research in TDD has been going on for many years in the field of medical science; however, the translation of expectations and promises to clinical reality has not been satisfactorily achieved because of several challenges. The exploration of TDD ideas under the MC and MN paradigms is considered as an option to addressing these challenges and to facilitate the translation of TDD from the bench to the patients' bedsides. Over the past decade, there have been some research efforts made in exploring the ideas of TDD on the MC and MN platforms. While the number of research output in terms of scientific articles is few at the moment, the desire in the scientific community to participate in realizing the goal of TDD is quite high as is evidence from the rise in research output over the last few years. To increase awareness and provide the multidisciplinary research community with the necessary background information on TDD, this paper presents a visionary survey of this subject within the domain of MC and MN. We start by introducing in an elaborate manner, the motivation behind the application of MC and MN paradigms to the study and implementation of TDD. Specifically, an explanation on how MC-based TDD concepts differ from traditional TDD being explored under the field of medical science is provided. We also summarize the taxonomy of the different perspectives through which MC-based TDD research can be viewed. System models and design challenges/requirements for developing MC-based TDD are discussed. Various metrics that can be used to evaluate the performance of MC-based TDD systems are highlighted. We also provide a discussion on the envisaged path from contemporary research activities to clinical implementation of the MC-based TDD. Finally, we discuss issues such as informatics and software tools, as well as issues that border on the requirement for standards and regulatory policies in MC-based TDD research and practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002 · cited 5×
“It is shown in [330] that unlike spherical nanoparticles, nonspherical particles, such as those possessing discoidal geometries, are more prone to tumbling and”
BackgroundInfluentialGlobal quantification of mammalian gene expression control
Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., & Selbach, M. (2011) · Nature · doi:10.1038/nature10098 · Cited by 6,566 · cited 1×
“This requirement for an ATDD application is associated with the effectiveness of a nanosystem to synthesize information molecules in relation to the cellular resources available to it [295], [296].”
BackgroundCancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558
ZINC − A Free Database of Commercially Available Compounds for Virtual Screening
Irwin, J. J., & Shoichet, B. K. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci049714+ · Cited by 4,058
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Longmire, M., Choyke, P. L., & Kobayashi, H. (2008) · Nanomedicine · doi:10.2217/17435889.3.5.703 · Cited by 2,149
Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake
Walkey, C. D., Olsen, J. B., Guo, H., Emili, A., & Chan, W. C. W. (2012) · Journal of the American Chemical Society · doi:10.1021/ja2084338 · Cited by 1,926
Bashkatov, A. N., Genina, E. A., Kochubey, V. I., & Tuchin, V. V. (2005) · Journal of Physics D: Applied Physics · doi:10.1088/0022-3727/38/15/004 · Cited by 1,720
Polymers for Drug Delivery Systems
Liechty, W. B., Kryscio, D. R., Slaughter, B. V., & Peppas, N. A. (2010) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-073009-100847 · Cited by 1,608
Yin Win, K., & Feng, S.-S. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.07.050 · Cited by 1,452
A vesicle bioreactor as a step toward an artificial cell assembly
Noireaux, V., & Libchaber, A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408236101 · Cited by 1,152
A Comprehensive Survey of Recent Advancements in Molecular Communication
Farsad, N., Yilmaz, H. B., Eckford, A., Chae, C.-B., & Guo, W. (2016) · IEEE Communications Surveys & Tutorials · doi:10.1109/comst.2016.2527741 · Cited by 968
Optimality and evolutionary tuning of the expression level of a protein
Dekel, E., & Alon, U. (2005) · Nature · doi:10.1038/nature03842 · Cited by 766
Enzyme-responsive nanoparticles for drug release and diagnostics
de la Rica, R., Aili, D., & Stevens, M. M. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.01.002 · Cited by 765 · cited 1×
“More also, the diagnostic capability of nanoparticles [71] can”
BackgroundE-CELL: software environment for whole-cell simulation
Tomita, M., Hashimoto, K., Takahashi, K., Shimizu, T. S., Matsuzaki, Y., Miyoshi, F., Saito, K., Tanida, S., Yugi, K., Venter, J. C., et al. (1999) · Bioinformatics · doi:10.1093/bioinformatics/15.1.72 · Cited by 764
Delivery of Molecular and Nanoscale Medicine to Tumors: Transport Barriers and Strategies
Chauhan, V. P., Stylianopoulos, T., Boucher, Y., & Jain, R. K. (2011) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-061010-114300 · Cited by 597
Physicochemical modelling of cell signalling pathways
Aldridge, B. B., Burke, J. M., Lauffenburger, D. A., & Sorger, P. K. (2006) · Nature Cell Biology · doi:10.1038/ncb1497 · Cited by 592
Cell or Cell Membrane-Based Drug Delivery Systems
Tan, S., Wu, T., Zhang, D., & Zhang, Z. (2015) · Theranostics · doi:10.7150/thno.11852 · Cited by 466
Nanotheranostics and image-guided drug delivery: current concepts and future directions
Lammers, T., Kiessling, F., Hennink, W. E., & Storm, G. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100228v · Cited by 397
Diffusion of Macromolecules in the Brain: Implications for Drug Delivery
Wolak, D. J., & Thorne, R. G. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300495e · Cited by 299
Clemens, D. L., Lee, B.-Y., Xue, M., Thomas, C. R., Meng, H., Ferris, D., Nel, A. E., Zink, J. I., & Horwitz, M. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06049-11 · Cited by 260
Khan, E., Al Hossain, F., Uddin, S. Z., Alam, S. K., & Hasan, M. K. (2016) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2015.2466075 · Cited by 153
The potential of magneto-electric nanocarriers for drug delivery
Kaushik, A., Jayant, R. D., Sagar, V., & Nair, M. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.933803 · Cited by 113
Internet of nano-things healthcare applications: Requirements, opportunities, and challenges
Ali, N. A., & Abu-Elkheir, M. (2015) · 2015 IEEE 11th International Conference on Wireless and Mobile Computing, Networking and Communications (WiMob) · doi:10.1109/wimob.2015.7347934 · Cited by 70
Shiraishi, K., Sanada, Y., Mochizuki, S., Kawano, K., Maitani, Y., Sakurai, K., & Yokoyama, M. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.02.017 · Cited by 51
Cited by
A Survey on Green 6G Network: Architecture and Technologies
Huang, T., Yang, W., Wu, J., Ma, J., Zhang, X., & Zhang, D. (2019) · IEEE Access · doi:10.1109/access.2019.2957648 · Cited by 562
Channel Modeling for Diffusive Molecular Communication—A Tutorial Review
Jamali, V., Ahmadzadeh, A., Wicke, W., Noel, A., & Schober, R. (2019) · Proceedings of the IEEE · doi:10.1109/jproc.2019.2919455 · Cited by 357
Metadata
- Authors
- Chude-Okonkwo, U. A. K., Malekian, R., Maharaj, B. T., & Vasilakos, A. V.
- Venue
- IEEE Communications Surveys & Tutorials
- Published
- 2017
- Volume
- 19
- Issue
- 4
- Pages
- 3046-3096
- ISSN
- 1553-877X (ISSN-L)
- OpenAlex
- W2614985500
- Cited by
- 208
- References
- 25
- FWCI
- 8.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.